Mao Yang - Publications

UCHL3 Promotes Triple-Negative Breast Cancer Metastatic Potential Through Enhancing Cell Migration and Invasion.

Journal: Applied biochemistry and biotechnology

Published: February 24, 2026

miR-96-5p antagonizes FOXQ1-driven WNT/β-catenin signaling to inhibit triple-negative breast cancer.

Journal: Scientific reports

Published: April 27, 2025

HER2/PI3K/AKT pathway in HER2-positive breast cancer: A review.

Journal: Medicine

Published: June 14, 2024

TNFAIP3 promotes ALDH-positive breast cancer stem cells through FGFR1/MEK/ERK pathway.

Journal: Medical oncology (Northwood, London, England)

Published: July 27, 2022

TNFAIP3 mediates FGFR1 activation-induced breast cancer angiogenesis by promoting VEGFA expression and secretion.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 10, 2022

The FGFR1 Signaling Pathway Upregulates the Oncogenic Transcription Factor FOXQ1 to Promote Breast Cancer Cell Growth.

Journal: International journal of biological sciences

Published: April 30, 2022

HC-1119, a deuterated Enzalutamide, inhibits Migration, Invasion and Metastasis of the AR-positive triple-negative breast Cancer cells.

Journal: Molecular biology reports

Published: March 18, 2022

TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.

Journal: Breast cancer research : BCR

Published: February 22, 2018